PL2651423T3 - Szczepy lactococcus lactis do stosowania w poprawie stanu trawienia - Google Patents

Szczepy lactococcus lactis do stosowania w poprawie stanu trawienia

Info

Publication number
PL2651423T3
PL2651423T3 PL10813085T PL10813085T PL2651423T3 PL 2651423 T3 PL2651423 T3 PL 2651423T3 PL 10813085 T PL10813085 T PL 10813085T PL 10813085 T PL10813085 T PL 10813085T PL 2651423 T3 PL2651423 T3 PL 2651423T3
Authority
PL
Poland
Prior art keywords
lactococcus lactis
lactis strains
improving digestive
digestive condition
condition
Prior art date
Application number
PL10813085T
Other languages
English (en)
Inventor
Biliana Lesic
Isabelle Chambaud
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of PL2651423T3 publication Critical patent/PL2651423T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL10813085T 2010-12-17 2010-12-17 Szczepy lactococcus lactis do stosowania w poprawie stanu trawienia PL2651423T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10813085.7A EP2651423B1 (en) 2010-12-17 2010-12-17 Lactococcus lactis strains for use in improving digestive condition
PCT/IB2010/055913 WO2012080789A1 (en) 2010-12-17 2010-12-17 Lactococcus lactis strains for use in improving digestive condition

Publications (1)

Publication Number Publication Date
PL2651423T3 true PL2651423T3 (pl) 2016-05-31

Family

ID=44502202

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10813085T PL2651423T3 (pl) 2010-12-17 2010-12-17 Szczepy lactococcus lactis do stosowania w poprawie stanu trawienia

Country Status (9)

Country Link
US (1) US9408878B2 (pl)
EP (1) EP2651423B1 (pl)
JP (1) JP5989661B2 (pl)
CN (1) CN103370073B (pl)
BR (1) BR112013015255A2 (pl)
ES (1) ES2557578T3 (pl)
PL (1) PL2651423T3 (pl)
RU (1) RU2567009C2 (pl)
WO (1) WO2012080789A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2970986T3 (es) * 2013-03-08 2024-06-03 Univ California Nanopartículas inorgánicas funcionalizadas con polifosfato como composiciones hemostáticas y métodos de uso
WO2015023268A1 (en) * 2013-08-13 2015-02-19 President And Fellows Of Harvard College Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis
US10383921B2 (en) 2013-08-13 2019-08-20 President And Fellows Of Harvard College Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis
AU2015337800B2 (en) * 2014-10-28 2021-05-27 Medlab Ip Pty Ltd Treatment for depression and depressive disorders
CN104382948A (zh) * 2014-11-21 2015-03-04 江南大学 乳酸乳球菌在治疗肠道疾病中的一种应用方法
JP6152231B1 (ja) * 2017-01-06 2017-06-21 株式会社日本バリアフリー 腸内フローラ改善剤
CA3069567A1 (en) * 2017-07-18 2019-01-24 Keio University Anti-bacterial composition against th1 cell-inducing bacteria
US11918611B2 (en) 2018-05-03 2024-03-05 Crigasseni Ag Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of diarrheal and other microbial diseases
CN113473998A (zh) * 2019-02-01 2021-10-01 农业食品和环境国家研究中心 用于预防和/或治疗内脏痛的乳酸乳球菌菌株
EP3957367A4 (en) * 2019-03-07 2023-03-22 Keio University ANTIBACTERIAL COMPOSITION AGAINST DRUG RESISTANT BACTERIA OR PRO-INFLAMMATORY BACTERIA
JP7469332B2 (ja) * 2019-05-13 2024-04-16 サミ－サビンサ グループ リミテッド フルクトフィリック乳酸産生細菌
WO2021002449A1 (ja) * 2019-07-03 2021-01-07 国立大学法人弘前大学 白神山地に生息するキハダ由来の新規乳酸菌
CA3146915A1 (en) * 2019-08-09 2021-02-18 Fanny LARRERE Fermented compositions and processes of preparing the same
CN117736943B (zh) * 2024-02-20 2024-05-24 山东中科嘉亿生物工程有限公司 一种改善肠易激综合征的复合菌剂及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740471B1 (fr) * 1995-10-31 1997-12-19 Gervais Danone Co Ferments lactiques, et leur utilisation pour l'obtention de produits hypocholesterolemiants
PE20030284A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
CN1684976A (zh) * 2002-09-25 2005-10-19 福冈县政府 乳酸菌产生的抗菌性物质
FR2855182B1 (fr) 2003-05-19 2005-08-05 Gervais Danone Sa Nouveaux procede et inoculum pour fermentation lactique acidifiante
JP4589618B2 (ja) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
KR101155735B1 (ko) * 2004-03-31 2012-06-12 가부시키가이샤 메이지 항균성 조성물
DK3067057T3 (da) 2005-09-28 2023-02-13 Nordic Rebalance As Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
JP5527690B2 (ja) * 2007-11-19 2014-06-18 株式会社明治 免疫調節性機能誘導剤及び食品組成物
ES2395838T3 (es) 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium

Also Published As

Publication number Publication date
JP2014501100A (ja) 2014-01-20
EP2651423B1 (en) 2015-09-30
RU2013132931A (ru) 2015-01-27
US20130336944A1 (en) 2013-12-19
CN103370073B (zh) 2017-12-05
ES2557578T3 (es) 2016-01-27
JP5989661B2 (ja) 2016-09-07
WO2012080789A1 (en) 2012-06-21
BR112013015255A2 (pt) 2016-09-13
US9408878B2 (en) 2016-08-09
EP2651423A1 (en) 2013-10-23
RU2567009C2 (ru) 2015-10-27
CN103370073A (zh) 2013-10-23

Similar Documents

Publication Publication Date Title
PL2651423T3 (pl) Szczepy lactococcus lactis do stosowania w poprawie stanu trawienia
HK1206390A1 (en) Bioprotection using lactobacillus paracasei strains
ZA201208977B (en) Probiotic strains for use in improving the enteric nervous system
HK1206391A1 (en) Bioprotection using lactobacillus rhamnosus strains
PL2498789T3 (pl) Probiotyczny szczep bifidobacterium
GB201016925D0 (en) Graphene oxide
PL2481299T3 (pl) Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
EP2554568A4 (en) POLYIMIDE NANOCOMPOSITE AND PROCESS FOR PREPARING THE SAME
EP2583651A4 (en) ROLLING CHAIR AND BED
EP2605688A4 (en) MULTI-WALLED GELASTIC MATTRESS SYSTEM
HK1188814A1 (zh) 增稠乳酸菌菌株
PL2539989T3 (pl) System napędowy i maszyna robocza
HUE057338T2 (hu) Tejtermék és eljárás
PL2521769T3 (pl) Pałeczki kwasu mlekowego z działaniem przeciwutleniającym
HK1201041A1 (en) Bacterial strains expressing methylase genes and uses thereof
PL2531039T3 (pl) Zastosowanie sialidazy w technologii mleczarskiej
ZA201208978B (en) Probiotic strains for use in improving transepithelial resistance
GB201014904D0 (en) Travel pillow
EP2648572A4 (en) BED SET
LT2531076T (lt) Antčiužinis
GB2477495A8 (en) Inflatable cushions
GB201005441D0 (en) Improvements in wheelchairs
TWM388255U (en) Pneumatic massage sofa
RS20100436A3 (en) Indigenous LACTOBACILLUS strains and their use as probiotics
ZA201104831B (en) Mattress